of ATP levels in L363 and KMS11 on treatment with low doses of ETC inhibitors for 24 hrs. n = 3 technical replicates. (e-g) Complex I, Complex III, Complex IV or Complex V inhibition with IACS-010759 (25nM), antimycin (5nM), sodium azide (0.1mM) or oligomycin (2.5nM), respectively, sensitizes the indicated myeloma cell lines to 0.5µM of venetoclax on treatment for 24 hrs. Cell viability assessed by AnnexinV/DAPI staining. n = 3 independent experiments. Data are presented as mean values +/-SEM. Adjusted p-values are calculated using a two-way ANOVA with post-hoc Dunnett's multiple comparisons test. Source data are provided as a source data file.
